Document Detail


Pathophysiologic bases for adjunctive therapies in the treatment and secondary prevention of acute myocardial infarction.
MedLine Citation:
PMID:  9541759     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Postmyocardial infarction (MI) survival has been steadily improving. This improvement has been due, in part, to the actions of the adjunctive medical therapies for the treatment of MI. Aspirin, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, and lipid-lowering agents have been shown to improve survival in the treatment and secondary prevention of MI. Nitrates have beneficial effects as well. These medications complement the reperfusion strategies through different mechanisms. Other adjunctive medical therapies, namely magnesium, antiarrhythmic agents, and calcium-channel blockers, have not been shown to improve mortality with routine post-MI use despite their theoretical benefits.
Authors:
D E Gutstein; V Fuster
Related Documents :
16460969 - A percutaneous swine model of myocardial infarction.
15457279 - Cardiac rupture in acute myocardial infarction with st segment elevation. clinical cour...
19118249 - Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome pati...
18753699 - Angiotensin-receptor blockade reduces border zone myocardial monocyte chemoattractant p...
20652649 - Chromium and manganese levels in biological samples of pakistani myocardial infarction ...
20854949 - Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospita...
8823649 - Testing the safety of baxter continuous cardiac output monitoring system.
19766919 - Ct applications in electrophysiology.
6226189 - Physiologic considerations in left ventricular hypertrophy.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical cardiology     Volume:  21     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-05-21     Completed Date:  1998-05-21     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  161-8     Citation Subset:  IM    
Affiliation:
Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029-6574, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Anticoagulants / therapeutic use
Antilipemic Agents / therapeutic use
Aspirin / therapeutic use
Calcium Channel Blockers / therapeutic use
Cyclooxygenase Inhibitors / therapeutic use
Humans
Magnesium / therapeutic use
Myocardial Infarction / drug therapy*,  physiopathology,  prevention & control
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anti-Arrhythmia Agents; 0/Anticoagulants; 0/Antilipemic Agents; 0/Calcium Channel Blockers; 0/Cyclooxygenase Inhibitors; 0/Vasodilator Agents; 50-78-2/Aspirin; 7439-95-4/Magnesium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Current knowledge and significance of coronary artery ectasia: a chronologic review of the literatur...
Next Document:  Evaluation of left atrial filling using systolic pulmonary venous flow velocity measurements in pati...